Last reviewed · How we verify
NCT05112757
Effective Conversion of Individuals at Risk
NA trial testing Smartphone application use in Obstructive Sleep Apnea in 77 participants. Terminated before completion.
8 December 2022
Quick facts
| Lead sponsor | Philips Electronics Nederland B.V. acting through Philips CTO organization |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 77 |
| Start date | 24 February 2022 |
| Primary completion | 8 December 2022 |
| Estimated completion | 8 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Smartphone application use
Conditions studied
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Philips Electronics Nederland B.V. acting through Philips CTO organization
Who can join
18 and older, any sex, with Obstructive Sleep Apnea or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these symptoms (if any) and inform the participants on their possible diagnosis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05112757
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea
Currently open trials in the same condition.
- NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
- NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
- NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting
Other Philips Electronics Nederland B.V. acting through Philips CTO organization trials
Trials by the same sponsor.
- NCT05748184 — Fast Ultra Low Dose CT Interpretation · terminated
- NCT05657665 — Skin Tone Measurement Method Investigation for Pulse Oximetry · completed
- NCT05089955 — Children's MRI Experience · NA · completed
- NCT05517096 — AmbuLatory Pediatric Asthma CAre · NA · withdrawn
- NCT05540444 — RadConnect Communication Application · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05112757 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philips Electronics Nederland B.V. acting through Philips CTO organization
- Last refreshed: 12 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05112757.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing